Gilbert & Cook’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $736K | Buy |
26,225
+677
| +3% | +$18K | 0.1% | 111 |
|
|
2025
Q4 | $636K | Buy |
25,548
+257
| +1% | +$6.48K | 0.08% | 130 |
|
|
2025
Q3 | $644K | Buy |
25,291
+572
| +2% | +$14.1K | 0.08% | 119 |
|
|
2025
Q2 | $599K | Buy |
24,719
+323
| +1% | +$7.53K | 0.08% | 117 |
|
|
2025
Q1 | $618K | Sell |
24,396
-1,297
| -5% | -$33.9K | 0.09% | 107 |
|
|
2024
Q4 | $682K | Buy |
25,693
+450
| +2% | +$12.2K | 0.1% | 104 |
|
|
2024
Q3 | $731K | Buy |
25,243
+700
| +3% | +$20.4K | 0.1% | 89 |
|
|
2024
Q2 | $687K | Sell |
24,543
-1,948
| -7% | -$53.6K | 0.1% | 88 |
|
|
2024
Q1 | $735K | Buy |
26,491
+840
| +3% | +$23.3K | 0.1% | 94 |
|
|
2023
Q4 | $738K | Buy |
25,651
+945
| +4% | +$28.6K | 0.1% | 92 |
|
|
2023
Q3 | $819K | Buy |
24,706
+1,915
| +8% | +$67.7K | 0.13% | 73 |
|
|
2023
Q2 | $836K | Buy |
22,791
+1,523
| +7% | +$59.3K | 0.13% | 59 |
|
|
2023
Q1 | $868K | Buy |
21,268
+283
| +1% | +$12.2K | 0.15% | 54 |
|
|
2022
Q4 | $1.08M | Buy |
20,985
+300
| +1% | +$14.4K | 0.2% | 42 |
|
|
2022
Q3 | $974K | Buy |
20,685
+303
| +1% | +$14.7K | 0.22% | 44 |
|
|
2022
Q2 | $1.07M | Buy |
20,382
+301
| +1% | +$15.3K | 0.19% | 42 |
|
|
2022
Q1 | $1.04M | Buy |
20,081
+2,750
| +16% | +$143K | 0.17% | 45 |
|
|
2021
Q4 | $1.02M | Buy |
17,331
+560
| +3% | +$27.7K | 0.16% | 48 |
|
|
2021
Q3 | $721K | Buy |
16,771
+739
| +5% | +$32.7K | 0.13% | 67 |
|
|
2021
Q2 | $628K | Buy |
16,032
+864
| +6% | +$33.6K | 0.11% | 75 |
|
|
2021
Q1 | $550K | Buy |
15,168
+1,640
| +12% | +$58.2K | 0.11% | 78 |
|
|
2020
Q4 | $500K | Buy |
13,528
+1,622
| +14% | +$59.5K | 0.11% | 73 |
|
|
2020
Q3 | $415K | Buy |
11,906
+1,049
| +10% | +$36.8K | 0.1% | 75 |
|
|
2020
Q2 | $337K | Buy |
10,857
+534
| +5% | +$18.1K | 0.08% | 87 |
|
|
2020
Q1 | $320K | Buy |
10,323
+301
| +3% | +$10.3K | 0.09% | 78 |
|
|
2019
Q4 | $373K | Buy |
10,022
+1,084
| +12% | +$38.6K | 0.09% | 80 |
|
|
2019
Q3 | $305K | Buy |
8,938
+441
| +5% | +$16K | 0.09% | 84 |
|
|
2019
Q2 | $349K | Buy |
8,497
+191
| +2% | +$7.58K | 0.1% | 73 |
|
|
2019
Q1 | $334K | Buy |
8,306
+146
| +2% | +$5.85K | 0.1% | 74 |
|
|
2018
Q4 | $338K | Sell |
8,160
-14
| -0.2% | -$581 | 0.12% | 66 |
|
|
2018
Q3 | $342K | Buy |
8,174
+99
| +1% | +$3.81K | 0.11% | 67 |
|
|
2018
Q2 | $278K | Buy |
8,075
+733
| +10% | +$25K | 0.09% | 72 |
|
|
2018
Q1 | $247K | Sell |
7,342
-40
| -0.5% | -$1.38K | 0.09% | 73 |
|
|
2017
Q4 | $254K | Sell |
7,382
-71
| -1% | -$2.42K | 0.09% | 73 |
|
|
2017
Q3 | $252K | Sell |
7,453
-9,271
| -55% | -$298K | 0.09% | 69 |
|
|
2017
Q2 | $532K | Buy |
16,724
+9,260
| +124% | +$292K | 0.19% | 52 |
|
|
2017
Q1 | $242K | Buy |
7,464
+784
| +12% | +$24.7K | 0.1% | 68 |
|
|
2016
Q4 | $206K | Buy |
+6,680
| New | +$204K | 0.09% | 75 |
|
Other funds holding PFE
VCM
VPM
Gilbert & Cook's PFE Position: Q1 2026 in Review
Gilbert & Cook increased its Pfizer (PFE) stake by 2.6% in Q1 2026, buying an estimated $18K and bringing the position to 26,225 shares worth $736K. The position accounts for 0.1% of the portfolio, ranked #111.
Gilbert & Cook first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.08M in Q4 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Gilbert & Cook held 26,225 shares of Pfizer worth $736K as of Q1 2026.
- Gilbert & Cook bought 677 Pfizer shares in Q1 2026, an estimated $18K.
- Pfizer made up 0.1% of Gilbert & Cook's portfolio in Q1 2026, its #111 holding.
- Gilbert & Cook first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
- Gilbert & Cook's Pfizer position peaked at $1.08M in Q4 2022.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Gilbert & Cook's 13F filing for Q1 2026, filed 5 May 2026.